Search company, investor...


Other Investors | Dead

About PhenoTech

PhenoTech, Inc. was founded in 2003 and funded by BioAdvance in March 2004. PhenoTech was created to develop University of Pennsylvania technology for the discovery, development and commercialization of monoclonal antibodies (mAbs) to be used in blood diagnostic and blood therapeutic applications. The company is in the process of winding down operations.

Headquarters Location

Philadelphia, Pennsylvania, 19019,

United States



Latest PhenoTech News

Lehua Brands Transforms CA State Fair Award-Winning Cannabis Strains into Delicious Beverages and Slushies (THC-Free) for CA Cannabis Exhibit

Jul 14, 2022

Lehua Brands Ltd. SACRAMENTO, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- via CannabisNewsWire -- The CA State Fair Cannabis Awards and Lehua Brands , the official beverage of the Awards, proudly present special edition TerpTonic beverages in collaboration with four of California’s most acclaimed cannabis cultivators. These special edition TerpTonic beverages and slushies will be available for purchase at the Lehua Brands booth (#13) within the CA Cannabis Exhibit at the CA State Fair in Expo Center Building One. Quantities may be limited. The cultivators and their award-winning strains include two Golden Bear “Best of California” winners, Esensia Gardens (Buddha’s Hand) and Greenshock Farms (Passion Orange Guava), and two Gold Medal winners, Booney Acres (Gelonade) and Emerald Spirit Botanicals (Pink Boost Goddess). “The CA State Fair Cannabis Awards is delighted to offer adult fairgoers the opportunity to experience these exceptional flower strains in a truly novel format,” said Cultivar Brands CEO James Leitz. “Lehua Brand’s beverages and slushies deliver the unique flavors and aromas of the plant, with enhanced CBD, but no THC. Lehua’s TerpTonics offer an ideal means to educate the consumer by experiencing the natural herbal complexity of the cannabis plant.” TerpTonics are formulated with no artificial flavors or sweeteners and only four essential ingredients: cured resin extract derived from the freshest cannabis flower, Cirona Lab’s specialty water-soluble emulsions, pure mineral water and terpene-infused CO₂ gas. Cured resin extract, TerpTonics’ core ingredient, is extracted using Lehua’s patented PhenoTech CO2 extraction technology, from single-source, single-strain premium cannabis flower grown by these award-winning cultivators. PhenoTech’s extraction process substantially preserves the chemical composition (aka the “chemovar”) that is native to each flower; everything unique to each strain is preserved in Lehua’s extract and each strain-specific TerpTonic. “Lehua’s technology, knowledge and expertise, built over more than a decade of experimentation and innovation, ensure that the consumer tastes the plant, not the process,” said Jon Fitzgerald, CEO, Lehua Brands. “Our mission is to create products that push the boundaries of traditional consumer experience. True to this mission, Lehua uses science to preserve nature.” All Lehua beverages and slushies served within the CA Cannabis Exhibit were manufactured in accordance with the rules and regulations of the California Department of Cannabis Control and satisfy the state’s requirement that hemp-based products have less than 0.3% THC by weight. About the California State Fair The CA State Fair is an international award-winning fair, receiving top honors at the International Association of Fairs and Expositions out of more than 1,100 fairs worldwide. The CA State Fair is dedicated as a place to celebrate the best California has to offer in agriculture, technology and the diversity of its people, traditions and trends that shape the Golden State’s future. The 2022 fair will be held July 15-July 31, at the Cal Expo Fairgrounds, 1600 Exposition Blvd, Sacramento, CA, 95815. Visit . About The California State Fair Cannabis Awards On June 23, 2022, the California State Fair Cannabis Awards announced the inaugural award-winning cultivars and cultivators from throughout California. More than 300 entries were evaluated for this year’s competition. A total of 60 trophies and medals were awarded, consisting of gold and silver medals by division and category, as well as the coveted Golden Bear Award for the “Best of California” overall winners. The awards were developed in partnership between the California Exhibition & State Fair and Cultivar Brands. Visit . About Cultivar Brands Inc. Cultivar Brands is a California-based strategic marketing agency specializing in cannabis travel and events. Our thought leadership at the forefront of the cannabis travel trend, brand consulting, and events expertise foster deep relationships within the cannabis and hemp industries. Visit . About Lehua Brands Ltd. Based in King City, Monterey County, Lehua is a licensed manufacturer and distributor of award-winning cannabis products. These include Olala craft sodas, VOILA! sparkling water, TerpTonic single-strain tonics, Herbology, HAKU Blue and HAKU Red vape cartridges, and soon-to-be-released TIKI Blast 100 mg high-potency elixir. PhenoTech Inc., a wholly owned technology company, specializes in the manufacture and sale of ingredients including, but not limited to, extracts and water-soluble emulsions in exclusive partnership with Cirona Labs. Visit . For commercial or media inquiries, please contact: Jon Fitzgerald, CEO ( ) or Brienna McWade, marketing manager ( ). Source: Lehua Brands Ltd.

PhenoTech Frequently Asked Questions (FAQ)

  • Where is PhenoTech's headquarters?

    PhenoTech's headquarters is located at Philadelphia.

  • What is PhenoTech's latest funding round?

    PhenoTech's latest funding round is Other Investors.

  • Who are the investors of PhenoTech?

    Investors of PhenoTech include BioAdvance.

  • Who are PhenoTech's competitors?

    Competitors of PhenoTech include Cevec Pharmaceuticals, United Biomedical, Banyan Biomarkers, Curetis, Oxford BioTherapeutics and 7 more.


Compare PhenoTech to Competitors

Oxford BioTherapeutics Logo
Oxford BioTherapeutics

Oxford BioTherapeutics is a clinical stage oncology company that operates in the healthcare and biotechnology sectors. The company primarily focuses on the development of first-in-class immune therapies and antibody-drug conjugates, which are designed to improve outcomes for cancer patients, particularly those who respond poorly to PD-1 inhibitors. These therapies work by re-engaging the patient's immune system and directly targeting cancer cells. It is based in Oxfordshire, England.


Indena is a company dedicated to the identification, development and production of active principles derived from plants, for use in the pharmaceutical, health-food and cosmetics industries. Indena, a privately owned Italian company, has around 700 employees, including 10% dedicated to full-time research, aims to manage cultivation, manufacturing, and distribution operations in more than 40 countries throughout the world. The key to Indena's success is its research, covering: the screening of medicinal plants for their pharmacological benefits; the identification of new active principles; and the development of extraction and purification systems at the cutting-edge of industrial application. The phyto-chemical research is carried out in Indena's own Research Center in Settala, Italy. Indena also co-operates with the world's most prestigious universities and private research institutions in the biological assessment of safety and effectiveness up to clinical phase I. One of the main strategic objectives of the research is the development of new active principles for pharmaceutical applications. This is also an indispensable base for the health-food and cosmetics industries. In the pharmaceutical sector Indena is currently focusing on the development of anti-cancer treatments, following the successes of paclitaxel, as well as on anti-microbial and on anti-viral drugs. Also under study are active principles for the treatment of pathologies and dysfunction of the central nervous system, such as depression, anxiety, impotence, sleep disorders, and algesia. Today Indena is also concentrating its efforts on the industrial production of high-quality standardised active principles derived from plants, which are important ingredients in health food products. In fact, the company produces standardised extracts from edible plants that are traditionally recognised as having therapeutic properties, as well as from plants that have proven pharmacological value. Indena's research and production activities are particularly attentive to plant-based principles that have anti-oxidant properties and are effective in preventing damage caused by free radicals. Backed by over 80 years of botanical experience, the Italian company has developed a plantation network, managed by experts, to supply its research and production centers with officinal plants, while at the same time ensuring bio-diversity and protecting the ecosystem balance from uncontrolled harvesting. Today more than 60% of the raw material used in the manufacturing process comes from cultivation. Indena's decades-long global presence in the plant extraction industry is a guarantee of its in-depth knowledge and understanding of the business, market trends and legal considerations, through constant communication and interaction between the company's experts and the major international regulatory authorities such as WHO, EMEA, and ESCOP, and main pharmacopoeias.

ImmunoReagents Logo

ImmunoReagents is a manufacturer of antibodies and reagents for the pharmaceutical, biotechnology, life science research, and in vitro diagnostics industries. The company offers a range of products including primary and secondary antibodies, ELISA and Western Blot reagents, and antibody purification tools. ImmunoReagents also provides bulk immunoassay reagents and OEM services for the production of research reagents and diagnostic immunoassays. It was founded in 2005 and is based in Raleigh, North Carolina.

Traversa Therapeutics

Traversa Therapeutics is a company that operates in the healthcare sector, with a focus on developing therapeutic treatments. The company's main offerings include the development and provision of various therapeutic treatments designed to address different health conditions. It was founded in 2006 and is based in La Jolla, California.


Chemopreventia focuses on the development of cancer preventive drugs and works on the mechanism of action of retinoids and other chemopreventive agents in the control of epithelial cancers. The company also focuses on the protein receptors that mediate the action of chemopreventive agents.

CoImmune Logo

CoImmune is a company that focuses on the development and manufacture of cell-based therapeutics, operating within the healthcare and biotechnology sectors. The company's main offerings include treatments for unmet medical needs such as cancer, autoimmune, and inflammatory diseases. It was founded in 1997 and is based in Durham, North Carolina. CoImmune operates as a subsidiary of Genexine and SCM Lifescience.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.